VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) ("Pure Extracts" or the "Company"), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has received an initial purchase order (PO) for its cannabis vape cartridges from Cannabis NB, the sole retailer of nonmedical cannabis in the province of New Brunswick.
温哥华，不列颠哥伦比亚省，2022年3月10日(环球通讯社)纯萃取技术公司(CSE：PRXTF)(场外交易代码：PRXTF)(XFRA：A2QJAJ)(“纯提取物”或“公司”)，一家专注于大麻、大麻、功能性蘑菇和迅速崛起的迷幻行业的植物性提取物公司，高兴地宣布，其全资子公司Pure Extracts Manufacturing Corp.收到了大麻蒸发盒的初步订单(PO)，该公司是印度非医用大麻的唯一零售商。
The Purchase Order (PO) is for 3 SKUs of 1.0 gram Pure Pulls branded vape cartridges filled with a selection of some of the Company's 30+ proprietary cannabis full-spectrum oil (FSO) and CBD formulations.
采购订单(PO)是3个1.0克的SKU Pure Pure品牌蒸汽盒，装满了该公司30多种专有大麻全光谱油(FSO)和CBD配方中的一部分。
Pure Extracts CEO, Ben Nikolaevsky, remarked, "We are pleased to be expanding our sales and brand awareness outside of British Columbia, Alberta, Saskatchewan and Ontario into Eastern Canada. The New Brunswick PO reflects both the high-quality of our products and the consumer demand for legacy brands."
ON BEHALF OF THE BOARD
CEO and Director
About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company's stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
Pure Extracts Technology Corp.拥有一个全新的、最先进的加工设施，位于世界著名的不列颠哥伦比亚省惠斯勒以北仅20分钟车程。这个定制设施是按照欧盟GMP标准建造的，旨在将产品和配方(包括目前在加拿大受到限制的产品和配方)出口到合法可获得的欧洲司法管辖区。根据2020年9月25日的大麻法案和2021年7月19日的销售修正案，纯萃取物获得了加拿大卫生部颁发的标准加工许可证。该公司的股票于2020年11月5日在加拿大证券交易所(CSE)开始交易。
Find out more at
Pure Extracts Investor Relations
Tel: +1 604 493 2052
This news release contains forward-looking statements relating to the future operations of Pure Extracts, and the other statements are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts', are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company's expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under "Risk Factors" in the Company's Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.
本新闻稿包含与Pure Extract公司未来运营有关的前瞻性陈述，其他陈述不是历史事实。前瞻性陈述通常由诸如“将”、“可能”、“应该”、“预期”、“期望”和类似的表达方式来识别。本新闻稿中除历史事实陈述外的所有陈述，包括但不限于有关Pure Extract的未来计划和目标的陈述，均为前瞻性陈述，涉及风险和不确定因素。许多因素可能导致实际事件、业绩或结果与前瞻性陈述中预测的大不相同。尽管我们认为这些陈述背后的假设是合理的，但它们可能被证明是不正确的，我们不能保证实际结果与这些前瞻性陈述一致。鉴于这些风险、不确定性和假设，投资者不应过度依赖这些前瞻性陈述。无论实际结果、业绩或成就是否符合公司的预期和预测，都会受到许多已知和未知的风险、不确定性、假设和其他因素的影响，包括那些在公司年度信息表格中的“风险因素”中列出的因素。除非适用的证券法要求，否则公司不承诺更新任何前瞻性信息。
This news release contains information about potential sales revenue from supply agreements, which may be considered as disclosure of financial outlook under applicable securities laws. Such information is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraph. Specifically, estimated sales revenue which may be derived from supply contracts has been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. The financial outlook contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the potential revenue which may be derived from any agreements recently entered into by the Company and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.
The CSE has neither approved nor disapproved the contents of this press release.